OCT 16, 2015 8:56 AM PDT

A Cure for Ebola?

WRITTEN BY: Kerry Evans
This isn’t the first time I’ve written about Ebola (and it probably won’t be the last).  Recently, a number of techniques for quickly diagnosing Ebola have been developed, and could make it to market in the (hopefully near) future.  Until now, however, there has been little progress towards vaccines or therapeutics for the virus.  Researchers at the US Army Medical Research Institute of Infectious Diseases and Gilead Sciences isolated a compound called GS-5734 that cured monkeys of Ebola virus disease (EVD).  
 
GS-5734 is a promising Ebola therapeutic.

Ebola virus causes a devastating hemorrhagic fever in humans and non-human primates, where the average survival rate is about 50%.  Clinicals symptoms include fever, headaches, vomiting, and bleeding, both internal and external.  Death often results from low blood pressure and overall fluid loss.  

GS-5734 is a nucleotide analog that inhibits the viral RNA polymerase, but does not affect host polymerases (an important consideration).  The group first tested the ability of GS-5734 to inhibit Ebola virus replication in human cell culture.  Next, they treated one group of Ebola-infected monkeys with 3 mg/kg of GS-5734, but only 50% of them survived.  They treated a second set of monkeys with a higher dose of the drug, 10 mg/kg, and all of the monkeys survived.  Clinical symptoms of EVD such as excessive bleeding were also reduced.  Although viral load was significantly decreased, it does not appear that the monkeys were “cured” of the virus.

GS-5734 was also effective against other Filoviruses such as Marburg, indicating it could serve as a broad-spectrum anti-viral.  However, the fact that Ebola virus was still detectable in the “cured” monkeys leaves me only cautiously optimistic.      

Check out the following video for information on Ebola gene-silencing technology being developed in Canada by Tekmira.  
 

Sources: ID Week 2015, Medical News Today, Genome Web, Wikipedia
 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
APR 16, 2020
Microbiology
APR 16, 2020
How Many COVID-19 Cases Have There Really Been?
It's widely accepted that we don't have a good idea of how many COVID-19 cases are circulating, so researchers are using ...
MAY 04, 2020
Genetics & Genomics
MAY 04, 2020
Molecular Tools Reveal More About the Impacts of the Slave Trade
Scientists still have a lot to learn about the numerous and varied consequences of the transatlantic slave trade, which ...
MAY 05, 2020
Microbiology
MAY 05, 2020
How a Microbe May Help Stop the Spread of Malaria
Scientists have discovered a bacterium that lives in mosquitoes around Lake Victoria, and appears to block malaria.
MAY 13, 2020
Microbiology
MAY 13, 2020
Low Vitamin D Levels Linked to COVID-19 Mortality
The COVID-19 pandemic has swept through various countries with widely discrepant mortality rates.
MAY 24, 2020
Microbiology
MAY 24, 2020
Cavity-Causing Microbes Are Protected by Rings of Sugars and Germs
Bacteria can form tough communities called biofilms, which are difficult to remove and can resist the effects of antimic ...
MAY 31, 2020
Microbiology
MAY 31, 2020
Zika Virus Infections in Early Life Can Cause Brain Damage
The Zika virus, which is transmitted by Aedes mosquitoes, poses significant risks to the developing fetus, and new work ...
Loading Comments...